| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT03508895 |
| P17 | country | Canada | Q16 |
| P582 | end time | 2019-08-01 | |
| P4135 | maximum age | 75 | |
| P1050 | medical condition | arterial hypertension | Q41861 |
| P2899 | minimum age | 18 | |
| P1132 | number of participants | 35 | |
| P4844 | research intervention | Caseins in emulsions: interfacial properties and interactions | Q58414129 |
| P8005 | research subject recruitment status | recruiting | Q76649708 |
| P859 | sponsor | University of Manitoba | Q1191833 |
| P580 | start time | 2018-07-16 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | Double Blind, Randomized, Cross Over Trial of Whole Hemp Seed Protein and Hemp Seed Protein Hydrolysate Derived Bioactive Peptide Consumption for Hypertension |